ABOS - Acumen Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABOS is currently covered by 4 analysts with an average price target of $8.14. This is a potential upside of $6.88 (546.03%) from yesterday's end of day stock price of $1.26.

Acumen Pharmaceuticals's activity chart (see below) currently has 22 price targets and 28 ratings on display. The stock rating distribution of ABOS is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ABOS is $11, Lowest price target is $9, average price target is $9.25.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 25-Aug-2025. First documented stock forecast 26-Jul-2021.

Currently out of the existing stock ratings of ABOS, 10 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$9

$7.74 (614.29%)

$4

27 days ago
(25-Aug-2025)

0/5 (0%)

$7.49 (496.03%)

Buy

$11

$9.74 (773.02%)

5 months 24 days ago
(28-Mar-2025)

0/8 (0%)

$9.81 (824.37%)

Buy

$6

$4.74 (376.19%)

$15

1 years 1 months 6 days ago
(15-Aug-2024)

0/3 (0%)

$3.42 (132.56%)

Buy

$11

$9.74 (773.02%)

$15

1 years 5 months 25 days ago
(27-Mar-2024)

0/2 (0%)

$6.9 (168.29%)

Buy

$13

$11.74 (931.75%)

$13

2 years 1 months 12 days ago
(09-Aug-2023)

0/5 (0%)

$6.22 (91.74%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABOS (Acumen Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?

PETE STAVROPOULOS

Which analyst has the most public recommendations on ABOS (Acumen Pharmaceuticals)?

Geoff Meacham works at BAML and has 12 price targets and 9 ratings on ABOS

Which analyst is the currently most bullish on ABOS (Acumen Pharmaceuticals)?

Pete Stavropoulos with highest potential upside - $11.74

Which analyst is the currently most reserved on ABOS (Acumen Pharmaceuticals)?

Colin Bristow with lowest potential downside - $4.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?